These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12547883)

  • 21. Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients.
    Derosa G; Maffioli P; Ferrari I; Palumbo I; Randazzo S; D'Angelo A; Cicero AF
    J Pharm Pharm Sci; 2010; 13(3):378-90. PubMed ID: 21092710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipose and muscle tissue profile of CD36 transcripts in obese subjects highlights the role of CD36 in fatty acid homeostasis and insulin resistance.
    Pietka TA; Schappe T; Conte C; Fabbrini E; Patterson BW; Klein S; Abumrad NA; Love-Gregory L
    Diabetes Care; 2014 Jul; 37(7):1990-7. PubMed ID: 24784828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.
    Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
    J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of rs3211938 polymorphism at CD36 to glucose levels, oxidized low-density lipoproteins, insulin resistance, and body mass index in Mexican mestizos with type-2 diabetes from western Mexico.
    Martín-Márquez BT; Sandoval-Garcia F; Vazquez-Del Mercado M; Martínez-García EA; Corona-Meraz FI; Fletes-Rayas AL; Zavaleta-Muñiz SA
    Nutr Hosp; 2021 Jul; 38(4):742-748. PubMed ID: 33966442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group.
    Avogaro A; Piliego T; Catapano A; Miola M; Tiengo A
    Acta Diabetol; 1999 Jun; 36(1-2):27-33. PubMed ID: 10436249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.
    Calanna S; Scicali R; Di Pino A; Knop FK; Piro S; Rabuazzo AM; Purrello F
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):670-6. PubMed ID: 24656139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
    Ahmad Khan H
    Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of carbohydrate metabolism disturbances in a population of children and adolescents with severe obesity].
    Guijarro De Armas MG; Monereo Megias S; Civantos Modino S; Montaño Martínez JM; Iglesias Bolaños P; Durán Martínez M
    Endocrinol Nutr; 2010 Dec; 57(10):467-71. PubMed ID: 21051299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.
    Du T; Yuan G; Zhou X; Sun X
    Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-Diabetics with Hypovitaminosis D Have Higher Risk for Insulin Resistance.
    Nur-Eke R; Özen M; Çekin AH
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients.
    Taniguchi A; Fukushima M; Seino Y; Sakai M; Yoshii S; Nagasaka S; Yamauchi I; Okumura T; Nin K; Tokuyama K; Yamadori N; Ogura M; Kuroe A; Nakai Y
    Metabolism; 2003 Oct; 52(10):1246-9. PubMed ID: 14564674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice.
    Goudriaan JR; Dahlmans VE; Teusink B; Ouwens DM; Febbraio M; Maassen JA; Romijn JA; Havekes LM; Voshol PJ
    J Lipid Res; 2003 Dec; 44(12):2270-7. PubMed ID: 12923231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.
    Lirussi F; Beccarello A; Zanette G; De Monte A; Donadon V; Velussi M; Crepaldi G
    Diabetes Nutr Metab; 2002 Aug; 15(4):222-31. PubMed ID: 12416659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.
    Chappuis B; Braun M; Stettler C; Allemann S; Diem P; Lumb PJ; Wierzbicki AS; James R; Christ ER
    Diabetes Metab Res Rev; 2007 Jul; 23(5):392-9. PubMed ID: 17211855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
    Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA
    Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.